Financials·Asset Management & Custody Banks·$13.4B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.38 | N/A | -2.81% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.38 | N/A | -2.81% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed caution regarding current market conditions. They emphasized their commitment to portfolio stability despite the challenges.
We are navigating a challenging market environment.
Our focus remains on maintaining strong portfolio performance.
The earnings report indicates that Ares Cap Corp faced some challenges, reflected in the slight miss on EPS. The stock's reaction, down 0.81%, suggests that investors are cautious about the company's performance amid a tough market. Without any guidance provided, uncertainty remains about future earnings potential.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ALNYLAM PHARMACEUTIC
May 6, 2013